Calyxt Reports First Quarter 2021 Financial Results
Successful Transformation of Hemp Genome Enables Step Change in Calyxt s Innovation Approaches in the Species
Promoted Sarah Reiter to the newly created role of Chief Business Officer
Scientific Advisory Board Formed, Diverse Scientific Expertise, and Proprietary Insights to Support Company Growth
Management to Host Conference Call Today at 4:30 p.m. ET
ROSEVILLE, MN / ACCESSWIRE / May 6, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, today announced financial results for its first quarter ended March 31, 2021. The first several months of 2021 included several exciting developments in our laboratories, the promotion of Sarah Reiter to Chief Business Officer, and the formation of our Scientific Advisory Board, with the scientific and technical expertise to guide us through the evolution of plant-based technology, said Yves Ribeill, Ph.D., Executive Chair. We also continued to execute on products in our
Calyxt Reports Fourth Quarter and Full Year 2020 Financial Results
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Calyxt Reports Fourth Quarter and Full Year 2020 Financial Results
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Calyxt Reports Fourth Quarter and Full Year 2020 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Calyxt Completes New Scientific Advisory Board with Key Appointments
New Strategic Initiative to Identify High Value Plant-Derived Products Utilizing Calyxt s Proprietary Innovation Platform
ROSEVILLE, MN / ACCESSWIRE / March 2, 2021 /
Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, has completed key appointments to its previously announced Scientific Advisory Board (SAB) to identify high value plant-derived product targets that will be produced utilizing Calyxt s proprietary innovation platform.
The SAB will provide guidance for Calyxt to leverage and grow the business in new directions and will explore opportunities in plant-derived ingredients for therapeutics, cosmetics, advanced materials, fragrance, flavor, color, and more. The SAB will identify both near-term opportunities and long-term technological breakthroughs, some of which may be realized through partnerships.